14 Assessment of the immunogenicity and protective efficiency of a novel dual-promoter DNA vaccine, harboring SAG1 and GRA7 genes, from RH strain of Toxoplasma gondii in BALB/c mice

15 Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus

16 Recent advances in Staphylococcus aureus infection: focus on vaccine development

17 Further considerations on rotavirus vaccination and seizure-related hospitalization rates

18 Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach

19 Awareness of primary health care physicians about human papilloma virus infection and its vaccination: a cross-sectional survey from multiple clinics in Saudi Arabia

20 A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile

21 Phenotypic and molecular characteristics of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolated from pigs: implication for livestock-association markers and vaccine strategies

22 Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease

23 Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public

24 Meningococcal conjugate vaccines: optimizing global impact

25 Review of oral cholera vaccines: efficacy in young children

26 Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease

27 Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

28 CONTENT REVIEW OF VACCINES AND VACCINATION RELATED NEWS IN INTERNET NEWSPAPERS

29 Assessment of the immunogenicity and protective efficiency of a novel dual-promoter DNA vaccine, harboring SAG1 and GRA7 genes, from RH strain of Toxoplasma gondii in BALB/c mice

30 Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus

31 CONTENT REVIEW OF VACCINES AND VACCINATION RELATED NEWS IN INTERNET NEWSPAPERS

32 Assessment of the immunogenicity and protective efficiency of a novel dual-promoter DNA vaccine, harboring SAG1 and GRA7 genes, from RH strain of Toxoplasma gondii in BALB/c mice

33 Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus

34 Immunoinformatics Approach for Multiepitopes Vaccine Prediction against Glycoprotein B of Avian Infectious Laryngotracheitis Virus

35 Recent advances in Staphylococcus aureus infection: focus on vaccine development

36 Further considerations on rotavirus vaccination and seizure-related hospitalization rates

37 Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach

38 Awareness of primary health care physicians about human papilloma virus infection and its vaccination: a cross-sectional survey from multiple clinics in Saudi Arabia

39 A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile

40 Phenotypic and molecular characteristics of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolated from pigs: implication for livestock-association markers and vaccine strategies

41 Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease

42 Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public

43 Meningococcal conjugate vaccines: optimizing global impact

44 Review of oral cholera vaccines: efficacy in young children

45 Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease

46 Vaccine Prophylaxis of Pneumococcal Infections in Children under Conditions of Severe Flood in the Amur River Basin

47 Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

48 Immunological response to Brucella abortus strain 19 vaccination of cattle in a communal area in South Africa

49 Immunogenicity of a plasmid DNA vaccine encoding G1 epitope of bovine ephemeral fever virus G glycoprotein in mice

50 Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania

51 Age-appropriate vaccination coverage and its associated factors for pentavalent 1-3 and measles vaccine doses, in northeast Ethiopia: A community-based cross-sectional study.

52 The Public Health Benefits and Economic Value of Routine Yellow Fever Vaccination in Colombia

53 Acceptability and Feasibility of Delivering Pentavalent Vaccines in a Compact, Prefilled, Autodisable Device in Vietnam and Senegal.

54 At the bench: Engineering the next generation of cancer vaccines.

55 Minipigs as a neonatal animal model for tuberculosis vaccine efficacy testing.

56 Paid maternity leave and childhood vaccination uptake: Longitudinal evidence from 20 low-and-middle-income countries.

57 Immunological efficacy of Vaccination against Measles in Children with Down syndrome

58 "You need to do your research": Vaccines, contestable science, and maternal epistemology.

59 Strengths, pitfalls, and lessons learned in implementing electronic collection of childhood vaccination data in Zambia: The SmartCare experience.

60 Trends in the travelers' demand for pre-travel medical advice at a Spanish International Vaccination Center between 2000 and 2017.

61 Awareness, perceptions and intent to comply with the prospective malaria vaccine in parts of South Eastern Nigeria.

62 THE POTENTIAL PUBLIC HEALTH IMPACT OF HERPES ZOSTER VACCINATION IN THE 65 YEARS OF AGE COHORT IN ITALY.

63 Understanding Public Perceptions of the HPV Vaccination Based on Online Comments to Canadian News Articles.

64 The art of partnerships for vaccines.

65 The costs of delivering vaccines in low- and middle-income countries: Findings from a systematic review.

66 A Scoping Review of Investment Cases for Vaccines and Immunization Programs.

67 Inactivated Rabies Virus-Vectored Immunocontraceptive Vaccine in a Thermo-Responsive Hydrogel Induces High and Persistent Antibodies against Rabies, but Insufficient Antibodies against Gonadotropin-Releasing Hormone for Contraception.

68 Development of a SFTSV DNA vaccine that confers complete protection against lethal infection in ferrets.

69 Development of novel subunit vaccine based on truncated fiber protein of egg drop syndrome virus and its immunogenicity in chickens.

70 Felis catus papillomavirus type 2 virus-like particle vaccine is safe and immunogenic but does not reduce FcaPV-2 viral loads in adult cats

71 A Perfect Storm: Increased Colonization and Failure of Vaccination Leads to Severe Secondary Bacterial Infection in Influenza Virus-Infected Obese Mice

72 The future of vaccine development.

73 AAV-Mediated Expression of Broadly Neutralizing and Vaccine-like Antibodies Targeting the HIV-1 Envelope V2 Region.

74 Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans.

75 A Randomized, Double-blind, Active-controlled Phase III Trial of a Cell Culture-derived Quadrivalent Inactivated Influenza Vaccine in Healthy South Korean Children and Adolescents 6 Months to 18 Years of Age.

76 Dangerous agent or saviour? HPV vaccine representations on online discussion forums in Romania.

77 A qualitative study of vaccination behaviour amongst female Polish migrants in Edinburgh, Scotland.

78 It's not all about autism: The emerging landscape of anti-vaccination sentiment on Facebook.

79 Oral cholera vaccination in hard-to-reach communities, Lake Chilwa, Malawi.

80 Oral cholera vaccine coverage in hard-to-reach fishermen communities after two mass Campaigns, Malawi, 2016

81 A systematic review of immunogenicity, clinical efficacy and safety of human papillomavirus vaccines in people living with the human immunodeficiency virus.

82 Designing a multi-epitope based vaccine to combat Kaposi Sarcoma utilizing immunoinformatics approach

83 A multivalent Kaposi sarcoma-associated herpesvirus-like particle vaccine capable of eliciting high titers of neutralizing antibodies in immunized rabbits

84 Selective Capture and Determination of Receptor-Binding Hemagglutinin in Influenza Vaccine Preparations Using a Coupled Receptor-Binding/RP-HPLC Assay

85 Student agreement regarding adequacy of didactic content and practical experiences of vaccination clinic business operations.

86 Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection.

87 Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope Recognition.

88 Alginate-chitosan coated layered double hydroxide nanocomposites for enhanced oral vaccine delivery.

89 Bordetella pertussis antigens encapsulated into N-trimethyl chitosan nanoparticulate systems as a novel intranasal pertussis vaccine

90 Chitosan nano-structure loaded with recombinant E. coli O157:H7 antigens as a vaccine candidate can effectively increase immunization capacity

91 Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses

92 Determinants of Seasonal Influenza Vaccine Uptake Among the Elderly in the United States: A Systematic Review and Meta-Analysis.

93 An HRM Assay to Differentiate Sheeppox Virus Vaccine Strains from Sheeppox Virus Field Isolates and other Capripoxvirus Species

94 Finding Reasons for Vaccination Hesitancy: Evaluating Semi-Automatic Coding of Internet Discussion Forums.

95 Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies - a comprehensive review

96 Knowledge, attitudes and practices of young people in Zimbabwe on cervical cancer and HPV, current screening methods and vaccination.

97 Induction of Immune Response in Animal Model Using Recombinant Anti-NDV Vaccine.

98 Vaccine financing in Nigeria: are we making progress towards self-financing/sustenance?

99 Current status and future prospects for the development of substance abuse vaccines.

100 Economic impact of contagious caprine pleuropneumonia and cost-benefit analysis of the vaccination programmes based on a one-year continuous monitoring of flocks in the arid and semi-arid lands of Kenya.

101 One of the recent attacks of smallpox in Europe: A massive vaccination campaign during the epidemic in Wrocław in 1963.

Keyword Connections

Journals

Research Groups

Bibliographies